Profit Or Loss [Abstract]

ABIONYX Pharma - Filing #2821124

Concept 2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2019-01-01 to
2019-12-31
2019-01-01 to
2019-12-31
Profit or loss [abstract]
Profit (loss) [abstract]
Revenue
0 EUR
0 EUR
Profit (loss) from operating activities
2 968 EUR
2 525 EUR
Finance income
1 195 EUR
4 858 EUR
Finance costs
113,000 EUR
446,000 EUR
Tax expense (income)
0 EUR
38,000 EUR
Profit (loss)
1 886 EUR
1 886 EUR
1 849 EUR
1 849 EUR
Earnings per share [text block]
Earnings per share [abstract]
Earnings per share [line items]
Basic earnings per share [abstract]
Basic earnings (loss) per share
8.00
9.00
Diluted earnings per share [abstract]
Diluted earnings (loss) per share
8.00
9.00

Talk to a Data Expert

Have a question? We'll get back to you promptly.